Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

André R A Marques

Showing results (1-10 of 30) with videos related to

Pageof 3
Sort By:
Journal of Cell Science|January 18, 2019
Lysosomal storage disorders - challenges, concepts and avenues for therapy: beyond rare diseasesAndré R A Marques, Paul Saftig
Cells|September 26, 2020
Cell Senescence, Multiple Organelle Dysfunction and AtherosclerosisGisela Machado-Oliveira, Cristiano Ramos, André R A Marques, et al.
Frontiers in Cell and Developmental Biology|April 15, 2021
Lysosome (Dys)function in Atherosclerosis-A Big Weight on the Shoulders of a Small OrganelleAndré R A Marques, Cristiano Ramos, Gisela Machado-Oliveira, et al.
Journal of Lipid Research|June 5, 2013
The LXR-IDOL axis defines a clathrin-, caveolae-, and dynamin-independent endocytic route for LDLR internalization and lysosomal degradationVincenzo Sorrentino, Jessica K Nelson, Elena Maspero, et al.
Biochimica Et Biophysica Acta. Molecular Basis of Disease|July 2, 2021
Analysis of cathepsin B and cathepsin L treatment to clear toxic lysosomal protein aggregates in neuronal ceroid lipofuscinosisAlessandro Di Spiezio, André R A Marques, Lina Schmidt, et al.
Neurobiology of Disease|November 8, 2022
Cathepsin D: Analysis of its potential role as an amyloid beta degrading proteaseLisa Gallwitz, Lina Schmidt, André R A Marques, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|February 7, 2015
Lentiviral gene therapy using cellular promoters cures type 1 Gaucher disease in miceMaria Dahl, Alexander Doyle, Karin Olsson, et al.
Molecular Genetics and Metabolism|January 12, 2016
Lyso-glycosphingolipid abnormalities in different murine models of lysosomal storage disordersMaria J Ferraz, André R A Marques, Paulo Gaspar, et al.
Plos One|January 16, 2016
Gpnmb Is a Potential Marker for the Visceral Pathology in Niemann-Pick Type C DiseaseAndré R A Marques, Tanit L Gabriel, Jan Aten, et al.
FEBS Letters|February 23, 2016
Lysosomal glycosphingolipid catabolism by acid ceramidase: formation of glycosphingoid bases during deficiency of glycosidasesMaria J Ferraz, André R A Marques, Monique D Appelman, et al.
Pageof 3

Showing results (1-10 of 30) with videos related to

Sort By:
Pageof 3
Journal of Cell Science|January 18, 2019
Lysosomal storage disorders - challenges, concepts and avenues for therapy: beyond rare diseasesAndré R A Marques, Paul Saftig
Cells|September 26, 2020
Cell Senescence, Multiple Organelle Dysfunction and AtherosclerosisGisela Machado-Oliveira, Cristiano Ramos, André R A Marques, et al.
Frontiers in Cell and Developmental Biology|April 15, 2021
Lysosome (Dys)function in Atherosclerosis-A Big Weight on the Shoulders of a Small OrganelleAndré R A Marques, Cristiano Ramos, Gisela Machado-Oliveira, et al.
Journal of Lipid Research|June 5, 2013
The LXR-IDOL axis defines a clathrin-, caveolae-, and dynamin-independent endocytic route for LDLR internalization and lysosomal degradationVincenzo Sorrentino, Jessica K Nelson, Elena Maspero, et al.
Biochimica Et Biophysica Acta. Molecular Basis of Disease|July 2, 2021
Analysis of cathepsin B and cathepsin L treatment to clear toxic lysosomal protein aggregates in neuronal ceroid lipofuscinosisAlessandro Di Spiezio, André R A Marques, Lina Schmidt, et al.
Neurobiology of Disease|November 8, 2022
Cathepsin D: Analysis of its potential role as an amyloid beta degrading proteaseLisa Gallwitz, Lina Schmidt, André R A Marques, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|February 7, 2015
Lentiviral gene therapy using cellular promoters cures type 1 Gaucher disease in miceMaria Dahl, Alexander Doyle, Karin Olsson, et al.
Molecular Genetics and Metabolism|January 12, 2016
Lyso-glycosphingolipid abnormalities in different murine models of lysosomal storage disordersMaria J Ferraz, André R A Marques, Paulo Gaspar, et al.
Plos One|January 16, 2016
Gpnmb Is a Potential Marker for the Visceral Pathology in Niemann-Pick Type C DiseaseAndré R A Marques, Tanit L Gabriel, Jan Aten, et al.
FEBS Letters|February 23, 2016
Lysosomal glycosphingolipid catabolism by acid ceramidase: formation of glycosphingoid bases during deficiency of glycosidasesMaria J Ferraz, André R A Marques, Monique D Appelman, et al.
Pageof 3